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Pyrin, encoded by MEFV gene, is conserved in humans and mice. Mutations in the MEFV gene are associated with the human 
autoinflammatory disease familial Mediterranean fever (FMF). Pyrin can interact with the inflammasome adaptor ASC and 
induce inflammatory caspase-1 activation in monocytic cells, but the physiological function of Pyrin has been unknown for 
many years. Here we summarize previous studies of Pyrin function under the context of FMF and immunity, and discuss a re-
cent study demonstrating that Pyrin forms an inflammasome complex for caspase-1 activation in innate immunity. Pyrin in-
flammasome detects inactivating modifications of host Rho GTPases by diverse bacterial toxins and infections, including 
Clostridium difficile glucosylating cytotoxin TcdB, FIC-domain adenylyltransferase effectors from Vibrio parahaemolyticus 
and Histophilus somni, ADP-ribosylating Clostridium botulinum C3 toxin as well as Burkholderia cenocepacia infection. The 
mode of Pyrin action, i.e., sensing pathogen virulence activity rather than directly recognizing a microbial molecule, represents 
a new paradigm in innate immunity. 
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1  Pattern recognition in innate immunity 
Both mammals and plants rely on a group of pattern recog-
nition receptors (PRRs) to detect the conserved pathogen- 
associated molecular pattern (PAMP) or danger-associated 
molecular pattern (DAMP), and mount an innate immune 
response to ensure a healthy organism [12]. In mammals, 
the dogma or prevailing concept in innate immune detection 
is that PRRs directly recognize a microbial product upon 
infection. This idea is best exemplified by identification and 
characterizations of the membrane-bound Toll-like recep-
tors (TLRs). TLRs are directly ligated by various PAMPs 
such as double-stranded RNA (dsRNA) (or Poly IC), com-
ponents of bacterial cell wall, and bacterial flagellin, which 
stimulates the transcription of many cytokines, chemokines 
and inflammatory mediators [3]. It has also been well estab-
lished that a family of receptor kinases in plants functions 
similarly as the TLRs in innate immune recognition of mi-
crobial products [4]. In the mammalian system, another 
family of PRRs, most of which are classified as NOD-like 
receptors (NLR), are proposed to function as cytosolic re-
ceptors for various PAMPs or DAMPs [56]. Human ge-
nome encodes more than 20 NLRs that are usually con-
served in mice. NLRs generally share the conserved struc-
tural organization, consisting of carboxyl-terminal leucine- 
rich repeat domains (LRR), a central nucleotide-binding 
oligomerization (NOD or NACHT) domain, and a variable 
amino-terminal protein-protein interaction module, which is 
a caspase recruitment and activation domain (CARD), a 
PYRIN domain, or baculovirus inhibitor of apoptosis repeat 
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domains (BIR). 
Several NLR-family members have been shown to as-
semble an inflammasome complex; the inflammasome often 
involves a PYRIN-CARD adaptor protein ASC and acti-
vates an inflammatory caspase called caspase-1 [79]. Ac-
tive caspase-1 further processes interleukin (IL)-1β/IL-18 
and induces macrophage inflammatory necrotic death called 
pyroptosis. Accumulating evidences in recent years suggest 
that the canonical caspase-1 inflammasome pathway in 
macrophage and dendritic cells is critical for cytosolic de-
fense against diverse bacterial infections [1011]. Notably, 
among all the NLRs, only the BIR-domain containing NAIP 
subfamily has been demonstrated to serve as the receptor 
and mediate the assembly of an inflammasome complex 
[1213]. NAIPs directly recognize cytosolic flagellin and 
components of bacterial type III secretion system, and acti-
vate caspase-1 through the CARD-domain NLR protein 
NLRC [1417]. 
The plant system, in addition to receptor kinase-mediated 
direct recognition of pathogen-derived molecules, appears 
to rely more on the intracellular disease resistance (R) pro-
tein to sense microbial infection. The R protein shares the 
similar structure as mammalian NLRs. It has been well ac-
cepted that the R protein often acts in an indirect means by 
detecting pathogen-induced modification of a host protein, 
i.e., the virulence activity of the pathogen, a model known 
as “guard hypothesis” [18]. For instance, Pseudomonas sy-
ringae type III effectors AvrB and AvrRpm1 can induce 
modifications of Arabidopsis RIN4, and thereby activate the 
RPM1 disease resistance protein; AvrRpt2 and AvrPphB 
proteolytically cleave RIN4 and PBS1, which is detected by 
RPS2 and RPS5, respectively [1820]. This “Guard Model” 
is effective in at least two aspects. First, it can help the host 
to distinguish the pathogenic from the non-pathogenic bac-
teria. Second, as different pathogens and toxins often target 
a few hot-spot pathways or target proteins in the host, per-
ception of the virulence activity rather than the virulence 
factor itself is advantageous for using a limited number of 
PRRs to cope with the large number of pathogenic organ-
isms. However, it has not been clear from the literature 
whether such indirect detection of pathogen virulence activ-
ity by PRRs also operates in mammalian innate immunity. 
2  Pyrin and familial Mediterranean fever 
In addition to the canonical NLR family, two cytosolic 
PYRIN-domain containing atypical NLR proteins, AIM2 
and Pyrin, can also mediate inflammasome assembly for 
caspase-1 activation. AIM2 recognizes cytosolic dou-
ble-strand DNA (dsDNA) and forms a complex with ASC 
to activate caspase-1 [2125]. Pyrin, also called marenostrin 
and TRIM20, is encoded by the MEFV gene that is highly 
conserved in humans and mice. Mutations in MEFV cause a 
hereditary autoinflammatory disease known as familial 
Mediterranean fever (FMF). FMF is an autosomal recessive 
disorder found mostly in ethnic groups living around the 
Mediterranean basin. The gene responsible for FMF is 
mapped to MEFV in the short arm of chromosome 16 
[2627] and more than 60 FMF-associated mutations in 
MEFV have been identified ((http://fmf.igh.cnrs.fr/ISSAID/ 
infevers/). FMF is clinically characterized by acute perito-
neal inflammation, skin rash, pleural and arthritic attack. 
MEFV-encoded Pyrin protein is highly expressed in periph-
eral blood leukocytes and bone marrow leukocytes, but not 
other tissues according to the Northern blotting analyses 
[27,28]. Stimulation of monocytes with proinflammatory 
agents such as interferon-γ, tumor necrosis factor- 
(TNF-), and bacterial lipopolysaccharide (LPS) can ro-
bustly induce the expression of MEFV, suggesting a role in 
the inflammatory signal cascades [28]. 
The apparent recessive nature of most MEFV mutations 
in FMF patients led to an early postulation that the disease 
mutations are loss-of-function in nature. As a result, it has 
long been believed that Pyrin is a negative regulatory of a 
certain inflammatory pathway, and that loss of Pyrin func-
tion is responsible for the increased inflammation seen in 
the FMF patients. This idea results in many controversies 
regarding the exact function of Pyrin. In particular, genetic 
deletion of Mefv in mice does not recapitulate the disease 
symptom; the knockout mice indeed show no obvious phe-
notypes in the absence of a stimulus and their cytokine and 
chemokine levels are comparable to those in the wild-type 
mice [2930]. An initial clue to this puzzle comes from the 
identification of ASC as a direct binding partner of Pyrin; 
Pyrin and ASC interact with each other through their 
N-terminal PYRIN domains [29,31]. Subsequent studies 
showed that Pyrin overexpression leads to caspase-1 activa-
tion in an ASC-dependent manner [3233]. In addition, cell 
based reconstitution studies in 293T and THP1 macrophag-
es showed that the disease associated PSTPIP1 mutant pro-
teins can bind to and activate the Pyrin inflammasome [34]. 
These analyses suggest a possible function of Pyrin in 
forming an ASC-containing inflammasome complex in in-
nate immunity, but are inconsistent with the idea of Pyrin 
negatively regulating inflammation and therefore not well 
accepted at that time. The conflict is resolved by a recent 
study of generating genetically engineered mice that bear 
the FMF-causing mutation in mouse Mefv [35]. The knock-
in mice develop the disease-like symptom with excessive 
IL-1β release, which is dependent on the presence of an 
intact Asc allele. These suggest that FMF disease mutations 
are actually gain-of-function and Pyrin functions together 
with ASC in an unknown inflammasome pathway. 
Pyrin contains a PYRIN domain at the N terminus (resi-
dues 1100). There has been only one FMF mutation 
(E148Q) found at the N-terminal region of Pyrin. This mu-
tation, outside of the PYRIN domain, is unlikely to affect 
ASC binding but may interfere with Pyrin activation by the 
1158 Yang JL, et al.   Sci China Life Sci   December (2014) Vol.57 No.12 
upstream signal. Besides the PYRIN domain, human Pyrin 
protein possesses a central “pseudo” tripartite motif and a 
C-terminal B30.2 domain. The tripartite motif in the large 
TRIM family of ubiquitin ligase proteins is composed of a 
RING finger followed by one or two B-box zinc fingers and 
a coil-coil domain. The RING domain in Pyrin lacks the 
complete set of zinc-binding cysteine and histidine residues 
and therefore is probably inactive as a ubiquitin ligase. The 
C-terminal B30.2 domain is functionally important given 
that two thirds of the known FMF-causing mutations are 
found in this region [36]. Knock-in mice expressing B30.2 
domain mutant Pyrin exhibit serious inflammatory respons-
es and constitutive caspase-1 activation [35]. Thus, the 
B30.2 domain likely maintains Pyrin in an inactive state in 
the absence of the stimulus. Structural studies show that the 
B30.2 domain of Pyrin adopts a β-sandwich structure com-
posed of two β-sheet layers [37]. The FMF-associated 
B30.2 domain mutations are all mapped to the loop regions 
linking the two β-sheet layers, consistent with the notion 
that the B30.2 domain is important for the inactive confor-
mation of Pyrin. Interestingly, the C-terminus of mouse 
Pyrin lacks the B30.2 domain but bears another domain not 
recognized by any bioinformatics tools. Given the highly 
conserved function between human and mouse Pyrin, the 
C-terminal domain in mouse Pyrin likely fulfils a similar 
function as the B30.2 domain in human Pyrin. 
3  Pyrin functions as an inflammasome sensor 
for pathogen modification and inactivation of 
Rho GTPases 
Despite more than 15 years of research, the physiological 
function of Pyrin in immunity remained elusive until a re-
cent study from our group [38]. The discovery starts from 
TcdB, a secreted protein toxin from Clostridium difficile. C. 
difficile is a Gram-positive bacterium responsible for the 
majority of hospital-acquired infectious diarrhea and antibi-
otic-associated pseudomembranous colitis. C. difficile 
causes severe intestinal inflammation when overgrowing in 
the digestive tract. TcdB, together with the highly similar 
TcdA toxin, are the two major virulence factor of C. difficile 
[3940]. TcdA and TcdB belong to the large clostridial cy-
totoxin (LCT) family of ~250308 kD in size, including the 
lethal toxin from Clostridium sordellii (TcsL) [4142]. All 
proteins in the LCT family are composed of an N-terminal 
catalytic domain and C-terminal domains responsible for 
entry and translocation of the toxin into mammalian host 
cells through the endocytosis pathway. The catalytic domain 
of TcdB is a glycosyltransferase that modifies and inacti-
vates Rho family of small GTPases in the host, leading to 
disruption of the actin cytoskeleton structure. Both TcdB 
and TcsL glucosylate the same threonine residue in the 
switch I region in Rho GTPases; TcdB can work on all three 
Rho subfamilies including Rho, Rac and Cdc42 while TcsL  
modifies Rac/Cdc42 and some Ras-related GTPases, but not 
the Rho subfamily [41].  
In this new study, we first discover that TcdB but not 
TcsL can induce robust activation of the caspase-1 inflam-
masome in mouse bone marrow macrophages in its 
Rho-glucosylation activity-dependent manner [38]. This 
indicates that glucosylation of the Rho subfamily (RhoA/B/ 
C) may activate an unknown inflammasome pathway. 
Through a well-designed screen in the 293T cells stably 
expressing the red fluorescent protein (RFP)-tagged ASC, 
we identify Pyrin, among a panel of NLR proteins examined, 
as the specific immune sensor that can support TcdB-   
induced RFP-ASC foci formation. The function of Pyrin in 
sensing the Rho glucosylation activity of TcdB and induc-
ing ASC aggregation-dependent caspase-1 activation is  
also confirmed in several mouse macrophages/dendritic 
cells as well as human monocytes. We further generate the 
Mefv-deficient mice by employing the CRISPR/Cas9-  
mediated genetic targeting and demonstrate that Mefv 
macrophage, in contrast to wild-type mouse bone marrow 
macrophage, is completely resistant to TcdB-induced caspa- 
se-1 inflammasome activation. 
TcdB and TcsL modification of Rho GTPase leads to 
disruption of actin cytoskeleton structure. However, we 
show that cytochalasin D and the actin crosslinking domain 
(ACD) from Vibrio cholerae RTX toxin [43], two estab-
lished actin polymerization-inhibiting agents, cannot induce 
the Pyrin inflammasome activation in mouse bone marrow 
macrophages. These, together with the inability of TcsL in 
inflammasome activation, suggest that covalent modifica-
tion of Rho among the Rho family is likely the cause of 
TcdB-induced Pyrin activation. We then take advantage of 
the unique activity of other well-known Rho-modifying 
effectors or toxins to confirm this hypothesis. Vibrio para-
haemolyticus VopS and Histophilus somni IbpA are recent-
ly identified effectors that contain catalytic FIC domains 
and modify a switch I side-chain hydroxyl group in Rho 
GTPases by a modification called adenylylation or AMPyl-
ation [4446]. VopS adenylylates the same threonine in 
Rho as TcdB, and the two FIC domains in IbpA modify a 
nearby tyrosine. C. botulinum C3 toxin is the first and most 
established Rho-modifying toxin and catalyzes ADP-   
ribosylation of RhoA on Asn-41 that is located at the 
boarder of switch I region [4749]. Using both primary 
bone marrow macrophages and dendritic cell reconstitution 
systems, we show that VopS, IbpA and C3 toxin all can 
stimulate Pyrin inflammasome activation, which, similar to 
TcdB, also require their Rho-modifying activities. These 
analyses provide a strong support that the Pyrin inflam-
masome responds to pathogen-induced covalent modifica-
tion of the switch I region in Rho GTPases and the resulting 
Rho inactivation in host cells. We further observe that the 
Rho-inactivation domain (RID) of Vibrio RTX toxin [50], 
which does not modify Rho but can induce the conversion 
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of Rho-GTP to Rho-GDP, appears to harbor no activity of 
stimulating Pyrin inflammasome. This suggests that Pyrin 
does not respond to Rho inactivation in general, which is 
beneficial in avoiding the unwanted deleterious autoin-
flammation, as Rho GTPases are constantly undergoing 
conversion between the GTP and GDP-bound forms in the 
physiological context. The fact that C3 toxin is highly spe-
cific for the Rho subfamily further indicates that modifica-
tion of the Rho subfamily is the major cause for Pyrin in-
flammasome activation observed with TcdB and other 
Rho-modifying toxins. Our analyses for the first time reveal 
the normal biological function of the FMF disease protein 
Pyrin and establish a novel inflammasome pathway in in-
nate immunity. 
To further extend the above finding and also probe the 
physiological significance of Pyrin sensing of Rho modifi-
cation and inactivation, we examine the role of Pyrin in-
flammasome in Burkholderia cenocepacia infection. It is 
known from previous studies that B. cenocepacia causes 
Rho inactivation in its type VI secretion system-dependent 
manner [5152]. We confirm this observation and further 
notice that B. cenocepacia infection can induce covalent 
modification of endogenous RhoA in macrophages. Con-
sistent with that B. cenocepacia-induced modification can 
block further ADP-ribosylation by C3 toxin, Asn-41 in 
RhoA in dendritic cells is found to be deamidated into as-
partic acid by B. cenocepacia in the type VI secretion sys-
tem-dependent manner. Importantly, we observe that B. 
cenocepacia infection also robustly stimulates inflam-
masome activation in bone marrow macrophages, which 
requires Pyrin in the host and the type VI secretion system 
in the bacteria. When endogenous RhoA, B and C are all 
efficiently knocked down by small interference RNAs 
(siRNAs), transient overexpression of the deamidated RhoA 
(N41D), but not the wild-type version, can evidently drive 
RFP-ASC foci formation, demonstrating that modification 
of RhoA is sufficient to induce Pyrin inflammasome activa-
tion. Lastly, we find that B. cenocepacia replication in 
Mefv/ and Asc/ macrophages are significantly higher than 
that in wild-type cells, highlighting a role of Pyrin inflam-
masome activation in limiting intracellular growth of the 
bacteria. At the animal level, B. cenocepacia infection of 
wild-type mice triggers severe lung inflammation, as indi-
cated by inflammatory cell infiltration, appearance of in-
tra-alveolar leukocytes and disruption of normal lung archi-
tecture, and importantly these inflammatory responses are 
strongly attenuated in the infected lungs of Mefv/ and 
Asc/ mice. These results establish an important role of the 
Pyrin inflammasome in innate immune defense against B. 
cenocepacia infection. 
4  Conclusion remarks and perspectives 
Our study establishes the physiological function of the FMF 
disease gene product Pyrin in innate immune sensing of 
pathogen modification and inactivation of host Rho 
GTPases (Figure 1). The modification is diverse in the 
chemical form, including glucosylation, AMPylation, 
ADP-ribosylation and deamidation, which takes place on 
different residues within or around the GTPase switch I 
region (Figure 1). Consistently, Pyrin does not appear to 
interact directly with modified Rho [38], suggesting an in-
direct activation by the virulence activity of bacterial path-
ogens. This distinguishes Pyrin as an immune sensor from 
most mammalian PRRs that often directly recognize a mi-
crobial product. As mentioned earlier, the R protein in plant 
innate immunity is established in detecting pathogen-   
induced modification of a host protein through an indirect 
mechanism. In this regard, Pyrin appears to guard host Rho 
GTPases in pathogen-induced modification and inactivation, 
and the mechanism of Pyrin action somewhat mimics the 
“Guard Model” in plant innate immunity. Such functional 
mechanism of Pyrin is particularly advantageous for another 
important aspect of mammalian innate immune detection. 
Mammals co-evolve with a large number of microbial or-
ganisms which include both pathogenic and non-pathogenic 
bacteria. Non-pathogenic bacteria such as commensals are 
sometimes beneficial to or an integrated part of a human 
body, particularly in an immune-balanced and healthy indi-
vidual. Specific sensing of pathogen-induced modification 
of Rho GTPases by Pyrin, together with the direct recogni-
tion of the type III secretion apparatus components by the 
NAIP family of inflammasome receptors [1314], helps to 
distinguish pathogenic bacteria from non-pathogenic ones, 
thereby resolving a long-standing puzzle in innate immune 
research. 
The absence of a direct interaction between Pyrin and 
modified Rho also suggests that Pyrin senses a signaling 
event downstream of Rho modification. The signaling 
mechanism underlying how Rho modification induces Pyrin 
activation will certainly be the major focus of future studies  
 
 
Figure 1  A schematic model for Pyrin inflammasome activation by di-
verse modifications of Rho GTPases by various pathogen and pathogenic 
factors. 
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on this topic. It is worth noting here that Pyrin has been 
shown to interact directly with actin and the Pyrin-ASC 
complex has been shown localized to the actin filamentous 
structure in previous studies [5354]. Another study has also 
identified PSTPIP1 as a binding partner for Pyrin in a yeast 
two-hybrid screen [55]. Interestingly, PSTPIP1 is proline 
serine threonine phosphatase-interacting protein involved in 
actin cytoskeleton organization. Genetic mutations of 
PSTPIP1 can cause the syndrome of pyogenic arthritis, py-
oderma gangrenosum, and acne (PAPA), a dominantly in-
herited autoinflammatory disorder [56]. Two PAPA syn-
drome mutations A230T and E250Q in PSTPIP1 can in-
crease the binding to Pyrin. The binding of these mutants to 
Pyrin can lead to activation of the pyrin inflammasome in a 
cell-based reconstitution system [34]. Meanwhile, the 
“pseudo” tripartite motif shown to be responsible for 
PSTPIP1 binding is also enriched in FMF-associated muta-
tions. These data suggest a possibility that PSTPIP1 might 
be involved in Pyrin activation by Rho-modifying toxins or 
effectors, which likely occurs on an actin cytoskeleton plat-
form. Moreover, it is worth mentioning that some bacterial 
and fungal toxins that induce ribotoxic stress have also been 
shown recently to activate the human Pyrin inflammasome 
in a 293T reconstitution system [57]. It will be interesting to 
find out how the ribotoxic stress and the Rho GTPase inac-
tivation pathways might converge to activate the Pyrin in-
flammasome. 
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